RealFeedApp Genetics did not increase success odds in new drug trials
Recent failures of Novartis and Novo Nordisk drugs highlight the gap between genetic promises and clinical results, casting doubt on AI cures.
- Field
- medicine and diagnostics
- What they did
- Researchers demonstrated that two new drugs, which lowered certain substances in the blood, did not prevent heart attacks and strokes.
- Why it matters
- These results make people more skeptical of technological promises to quickly cure all diseases.
#heart disease#pharmaceutical failure#ai hype#clinical trial
